Anzeige
++++++ Hydrograph bei 2,2 Mrd. $ - Warum dieser 50-Mio.-$-Graphen-Player explodieren könnte! ++++++
SIRONA BIOCHEM WKN: A0RM6R ISIN: CA82967M1005 Kürzel: ZSB Forum: Aktien Thema: Hauptdiskussion
0,0000
USD
-99,98 % -0,0051
8. Mai 2026, 02:10 Uhr,
Nasdaq OTC
Kommentare 102.764
G
Gast-754537400,
16.02.2024 16:57 Uhr
0
Early 2025 heißt ungefähr soviel wie soon in 2025 ? 😁
gr0unding,
16.02.2024 16:33 Uhr
0
Sirona Biochem Announces Plans For Commercial Launch of GlycoProteMim TFC-1326 in Early 2025
Sirona Biochem Corp. is pleased to announce the planned commercialization of GlycoProteMim™ through its subsidiary Sirona Laboratories. The company's Chief Scientific Officer, Dr. Geraldine Deliencourt-Godefroy, outlined the plan in a recent exclusive video interview with the Investing News Network.
In the interview, Dr. Deliencourt-Godefroy explained the company's plan to introduce a new line of anti-aging products containing GlycoProteMim™ under Sirona Laboratories. She explained that the products are scheduled to hit the North American, Canadian, and European markets in 2025.
Sirona Laboratories' product line is not just a collection of skincare essentials; but also a testament to our unwavering commitment to pushing the boundaries of anti-aging and cosmetic science.
The product line will include a 21-day ampoule anti-aging program pack, anti-aging facial creams, and an anti-wrinkle moisturizing hand cream, all of which will contain unique formulations with varying concentrations of GlycoProteMim™. Development and tests for the different product formulations are still ongoing.
Future Therapeutic Skincare Products
Anticellulite Treatment
Sirona Biochem is also advancing efforts to bring to market a distinct and innovative active compound, specially designed to effectively target and treat cellulite. A clinical trial is being scheduled. Once regulatory approval is obtained, the active will be used in a cream or serum that will become part of Sirona Laboratories' growing product line.
Given the absence of effective treatments in the market, our forthcoming potential solution for cellulite elimination presents a significant commercial opportunity.
r
rockharders,
16.02.2024 16:05 Uhr
0
schaut richtig madig aus, die verpackungen🤣
PeterG,
16.02.2024 15:56 Uhr
0
Ne, habe doch gesagt dass ich keinen Pfennig mehr in Sirona reinstecke. Wollte nur sagen dass jeder theoretisch seine Chance hatte... 😉
s
p
n
new_investor,
16.02.2024 12:43 Uhr
0
Letztes hatte jeder die Möglichkeit beim convertible offering mitzumachen. Da gab es ebenfalls Cash und Anteile 🤷♂️
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | DRONESHIELD LTD Hauptdiskussion | -2,92 % | |
| 2 | NVIDIA Hauptdiskussion | +0,76 % | |
| 3 | Dax Prognose | +1,75 % | |
| 4 | DAX Hauptdiskussion | +1,75 % | |
| 5 | PLUG POWER Hauptdiskussion | +1,51 % | |
| 6 | DeFi Technologies: Eine Perle? | +2,71 % | |
| 7 | Beyond Meat Hauptdiskussion | +5,31 % | |
| 8 | für alle, die es ehrlich meinen beim Traden. | ||
| 9 | TUI Hauptforum | +2,20 % | |
| 10 | Diginex | ±0,00 % | Alle Diskussionen |
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | DRONESHIELD LTD Hauptdiskussion | -2,92 % | |
| 2 | NVIDIA Hauptdiskussion | +0,64 % | |
| 3 | PLUG POWER Hauptdiskussion | +1,51 % | |
| 4 | DeFi Technologies: Eine Perle? | +2,55 % | |
| 5 | Beyond Meat Hauptdiskussion | +5,31 % | |
| 6 | TUI Hauptforum | +2,20 % | |
| 7 | Diginex | ±0,00 % | |
| 8 | Poet Technologies | +9,12 % | |
| 9 | SELLAS Life Sciences Group Hauptdiskussion | +16,02 % | |
| 10 | FREYR Battery Inc Registered Shs Hauptdiskussion | +28,76 % | Alle Diskussionen |